Understanding "understanding": An important step toward improving informed consent to research

AJOB Primary Research

Volumn 1, Issue 2, 2010, Pages 1-3

  Appelbaum, Paul S ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958803611     PISSN: 21507716     EISSN: 21507724     Source Type: Journal    
DOI: 10.1080/21507716.2010.499322     Document Type: Editorial

References (13)

1. Appelbaum, P. S., and T. Grisso. 2001. The MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR). Sarasota, FL: Professional Resource Press.
2. Appelbaum, P. S., C. W. Lidz, and T. Grisso. 2004. Therapeutic misconception in clinical research: Frequency and risk factors. IRB: Ethics & Human Research 26(2): 1-8; correction and clarification, 26(5): 18.
3. Daugherty C. K., D. M. Banik, L. Janish, and M. J. Ratain. 2000. Quantitative analysis of ethical issues in phase I trials: A survey interview study of 144 advanced cancer patients. IRB: Ethics and Human Research 22(3): 6-14.
4. Featherstone, K., and J. L. Donovan. 1998. Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. British Medical Journal 317(7167): 1177-1180.
5. Grisso, T., and P. S. Appelbaum. 1998. Assessing competence to consent to treatment: A guide for physicians and other health professionals. New York: Oxford University Press.
6. Hochhauser, M. 2008. Consent comprehension in the 21st century: What is missing? Drug Information Journal 42(4): 375-384.
7. Hutchison, C., C. Cowan, T. McMahon, and J. Paul. 2007. A randomised controlled study of an audiovisual patient information intervention on informed consent and recruitment to cancer clinical trials. British Journal of Cancer 97(6): 705-711.
8. Joffe, S., E. F. Cook, P. D. Cleary, J. W. Clark, and J. C. Weeks. 2001. Quality of informed consent in cancer clinical trials: a crosssectional survey. Lancet 358(9295): 1772-1777.
9. Kim S. Y. H., P. S. Appelbaum, J. Swan, T. S. Stroup, J. P. McEvoy, D. C. Goff, D. V. Jeste, J. S. Lamberti, A. Leibovici, and E. D. Caine. 2007. Determining when impairment constitutes incapacity for informed consent in schizophrenia research. British Journal of Psychiatry 191(1): 38-43.
10. Paasche-Orlow M. K., H. A. Taylor, and F. L. Brancati. 2003. Readability standards for informed consent forms as compared with actual readability. New England Journal of Medicine 348(8): 721-726.
11. Sand K., S. Kassa, and J. H. Loge. 2010. The understanding of informed consent information-Definitions and measurements in empirical studies. AJOB Primary Research 1(2): 4-24.
12. Verheggen, F. W. S. M. and F. C. B. van Wijmen. 1996. Informed consent in clinical trials. Health Policy 36(2): 131-153.
13. Williams B. F., J. K. French, H. D. White, and the HER0-2 consent substudy investigators. 2003. Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): A prospective observational study. Lancet 361(9361): 918-922.